Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | $1,530.0M | $562.0M | $1,504.0M | $571.0M | $854.0M | $473.0M | $47.0M | $704.0M | $1,034.0M | $837.0M | $1,010.0M | $353.0M | $596.0M | $1,107.0M | ($6,000.0K) | $1,375.0M | $1,132.0M | $1,316.0M | $914.0M | $1,703.0M |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Boston Scientific Corporation's last 12-month Free Cash Flow is $1,965.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, Boston Scientific Corporation's Free Cash Flow growth was 21.3%. The average annual Free Cash Flow growth rates for Boston Scientific Corporation have been 12.2% over the past three years, 25.0% over the past five years.
Over the last year, Boston Scientific Corporation's Free Cash Flow growth was 21.3%, which is higher than industry growth of (0.2%). It indicates that Boston Scientific Corporation's Free Cash Flow growth is Good.